HeartFlow, Inc. (HTFL)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
Business of Non-Invasive Coronary Artery Disease Detection Solutions	125.81M	87.17M
Business of Non-Invasive Coronary Artery Disease Detection Solutions Growth	44.32%	-
Total	125.81M	87.17M
Total Growth	44.32%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Dec 31, 2023
United States	115.04M	77.73M
United States Growth	48.00%	-
United Kingdom	5.19M	4.49M
United Kingdom Growth	15.43%	-
Japan	4.30M	4.00M
Japan Growth	7.34%	-
Rest of Europe	1.29M	954.00K
Rest of Europe Growth	35.22%	-
Total	125.81M	87.17M
Total Growth	44.32%	-

Source: S&P Global Market Intelligence.